In Orai3-overexpressing breast cancer cells, NEDD4L mediates the ubiquitination and degradation of its target proteins (including either p53 regulators or p53), inducing chemotherapy resistance (Hasna et al., 2018). Here, ORAI3 is linked to breast carcinoma.